<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31796595</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>116</Volume><Issue>51</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1.</ArticleTitle><Pagination><StartPage>25991</StartPage><EndPage>26000</EndPage><MedlinePgn>25991-26000</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1902483116</ELocationID><Abstract><AbstractText>Mutations in Cu/Zn superoxide dismutase (Sod1) have been reported in both familial and sporadic amyotrophic lateral sclerosis (ALS). In this study, we investigated the behavior of heteromeric combinations of wild-type (WT) and mutant Sod1 proteins A4V, L38V, G93A, and G93C in human cells. We showed that both WT and mutant Sod1 formed dimers and oligomers, but only mutant Sod1 accumulated in intracellular inclusions. Coexpression of WT and hSod1 mutants resulted in the formation of a larger number of intracellular inclusions per cell than that observed in cells coexpressing WT or mutant hSod1. The number of inclusions was greater in cells expressing A4V hSod1. To eliminate the contribution of endogenous Sod1, and better evaluate the effect of ALS-associated mutant Sod1 expression, we expressed human Sod1 WT and mutants in human cells knocked down for endogenous Sod1 (Sod1-KD), and in <i>sod1&#x394;</i> yeast cells. Using Sod1-KD cells we found that the WT-A4V heteromers formed higher molecular weight species compared with A4V and WT homomers. Using the yeast model, in conditions of chronological aging, we concluded that cells expressing Sod1 heterodimers showed decreased antioxidant activity, increased oxidative damage, reduced longevity, and oxidative stress-induced mutant Sod1 aggregation. In addition, we also found that ALS-associated Sod1 mutations reduced nuclear localization and, consequently, impaired the antioxidant response, suggesting this change in localization may contribute to disease in familial ALS. Overall, our study provides insight into the molecular underpinnings of ALS and may open avenues for the design of future therapeutic strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brasil</LastName><ForeName>Aline de Ara&#xfa;jo</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Federal University of Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Mariana Dias Castela</ForeName><Initials>MDC</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Federal University of Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhardt</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1348-8095</Identifier><AffiliationInfo><Affiliation>Department of Experimental Neurodegeneration, University Medical Center G&#xf6;ttingen, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center G&#xf6;ttingen, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biostructural Imaging of Neurodegeneration, University Medical Center G&#xf6;ttingen, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Queiroz</LastName><ForeName>Daniela Dias</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Federal University of Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Marcos Dias</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Institute of Chemistry, Federal University of Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Outeiro</LastName><ForeName>Tiago Fleming</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Experimental Neurodegeneration, University Medical Center G&#xf6;ttingen, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center G&#xf6;ttingen, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biostructural Imaging of Neurodegeneration, University Medical Center G&#xf6;ttingen, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Planck Institute for Experimental Medicine, 37075 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neuroscience, Newcastle University Medical School, NE2 4HH Newcastle Upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eleutherio</LastName><ForeName>Elis Cristina Araujo</ForeName><Initials>ECA</Initials><Identifier Source="ORCID">0000-0001-5842-2714</Identifier><AffiliationInfo><Affiliation>Institute of Chemistry, Federal University of Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil; eliscael@iq.ufrj.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008970" MajorTopicYN="N">Molecular Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sod1</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">heterodimers</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31796595</ArticleId><ArticleId IdType="pmc">PMC6926019</ArticleId><ArticleId IdType="doi">10.1073/pnas.1902483116</ArticleId><ArticleId IdType="pii">1902483116</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sirabella R., et al. , Ionic homeostasis maintenance in ALS: Focus on new therapeutic targets. Front. Neurosci. 12, 510 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6090999</ArticleId><ArticleId IdType="pubmed">30131665</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Tanaka F., Sobue G., Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 83, 329&#x2013;335 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22323772</ArticleId></ArticleIdList></Reference><Reference><Citation>Majoor-Krakauer D., Willems P. J., Hofman A., Genetic epidemiology of amyotrophic lateral sclerosis. Clin. Genet. 63, 83&#x2013;101 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12630951</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon R. A., Bunton-Stasyshyn R. K. A., Fisher E. M. C., Fratta P., Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 136, 2342&#x2013;2358 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang C. K., Liu Y., Thomas J., Zhang Y., Zheng X. F. S., Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat. Commun. 5, 3446 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4678626</ArticleId><ArticleId IdType="pubmed">24647101</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., et al. , Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261, 1047&#x2013;1051 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D. R., et al. , Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59&#x2013;62 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., et al. , Dimerization, oligomerization, and aggregation of human amyotrophic lateral sclerosis copper/zinc superoxide dismutase 1 protein mutant forms in live cells. J. Biol. Chem. 289, 15094&#x2013;15103 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031559</ArticleId><ArticleId IdType="pubmed">24692554</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil A. A., et al. , Implications of fALS mutations on Sod1 function and oligomerization in cell models. Mol. Neurobiol. 55, 5269&#x2013;5281 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5948255</ArticleId><ArticleId IdType="pubmed">28884318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., et al. , Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse. Hum. Mol. Genet. 18, 1642&#x2013;1651 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667291</ArticleId><ArticleId IdType="pubmed">19233858</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., et al. , Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7, 623&#x2013;643 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., et al. , Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl. Acad. Sci. U.S.A. 103, 7142&#x2013;7147 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447523</ArticleId><ArticleId IdType="pubmed">16636275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotherton T. E., Li Y., Glass J. D., Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro. Neurobiol. Dis. 49, 49&#x2013;56 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549044</ArticleId><ArticleId IdType="pubmed">22926189</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Durazo A., Whitelegge J. P., Borchelt D. R., Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. J. Neurochem. 108, 1009&#x2013;1018 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801375</ArticleId><ArticleId IdType="pubmed">19077113</ArticleId></ArticleIdList></Reference><Reference><Citation>Witan H., et al. , Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1. Neurobiol. Dis. 36, 331&#x2013;342 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19660548</ArticleId></ArticleIdList></Reference><Reference><Citation>Weichert A., et al. , Wild-type Cu/Zn superoxide dismutase stabilizes mutant variants by heterodimerization. Neurobiol. Dis. 62, 479&#x2013;488 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24200866</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves S. A., Matos J. E., Outeiro T. F., Zooming into protein oligomerization in neurodegeneration using BiFC. Trends Biochem. Sci. 35, 643&#x2013;651 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20561791</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira A. V., Vila&#xe7;a R., Santos C. N., Costa V., Menezes R., Exploring the power of yeast to model aging and age-related neurodegenerative disorders. Biogerontology 18, 3&#x2013;34 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27804052</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil A. A., et al. , The involvement of GSH in the activation of human Sod1 linked to FALS in chronologically aged yeast cells. FEMS Yeast Res. 13, 433&#x2013;440 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23496883</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N. E., et al. , Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 5, 13416 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G. H., Kim J. E., Rhie S. J., Yoon S., The role of oxidative stress in neurodegenerative diseases. Exp. Neurobiol. 24, 325&#x2013;340 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4688332</ArticleId><ArticleId IdType="pubmed">26713080</ArticleId></ArticleIdList></Reference><Reference><Citation>Peled-Kamar M., et al. , Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. U.S.A. 94, 3883&#x2013;3887 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC20536</ArticleId><ArticleId IdType="pubmed">9108073</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo V. D., Shadel G. S., Kaeberlein M., Kennedy B., Replicative and chronological aging in Saccharomyces cerevisiae. Cell Metab. 16, 18&#x2013;31 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392685</ArticleId><ArticleId IdType="pubmed">22768836</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo V. D., Fabrizio P., Chronological aging in Saccharomyces cerevisiae. Subcell. Biochem. 57, 101&#x2013;121 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4048025</ArticleId><ArticleId IdType="pubmed">22094419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaeberlein M., Lessons on longevity from budding yeast. Nature 464, 513&#x2013;519 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3696189</ArticleId><ArticleId IdType="pubmed">20336133</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlia-Ciommo A., Piano A., Leonov A., Svistkova V., Titorenko V. I., Quasi-programmed aging of budding yeast: A trade-off between programmed processes of cell proliferation, differentiation, stress response, survival and death defines yeast lifespan. Cell Cycle 13, 3336&#x2013;3349 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4614525</ArticleId><ArticleId IdType="pubmed">25485579</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez J. A., et al. , Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J. Biol. Chem. 277, 15932&#x2013;15937 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11854285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward L. J., et al. , Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 277, 15923&#x2013;15931 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida C. R., Gralla E. B., Valentine J. S., Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 91, 9906&#x2013;9910 (1994).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44926</ArticleId><ArticleId IdType="pubmed">7937915</ArticleId></ArticleIdList></Reference><Reference><Citation>Corson L. B., Strain J. J., Culotta V. C., Cleveland D. W., Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. U.S.A. 95, 6361&#x2013;6366 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27707</ArticleId><ArticleId IdType="pubmed">9600970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hough M. A., et al. , Dimer destabilization in superoxide dismutase may result in disease-causing properties: Structures of motor neuron disease mutants. Proc. Natl. Acad. Sci. U.S.A. 101, 5976&#x2013;5981 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC395908</ArticleId><ArticleId IdType="pubmed">15056757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastow E. L., Gourlay C. W., Tuite M. F., Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis. Biochem. Soc. Trans. 39, 1482&#x2013;1487 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21936838</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastow E. L., et al. , New links between SOD1 and metabolic dysfunction from a yeast model of Amyotrophic Lateral Sclerosis (ALS). J. Cell Sci. 129, 4118&#x2013;4129 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5117206</ArticleId><ArticleId IdType="pubmed">27656112</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabizadeh S., et al. , Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells. Proc. Natl. Acad. Sci. U.S.A. 92, 3024&#x2013;3028 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC42351</ArticleId><ArticleId IdType="pubmed">7708768</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Acerson M. J., Abdolvahabi A., Mowery R. A., Shaw B. F., Gibbs energy of superoxide dismutase heterodimerization accounts for variable survival in amyotrophic lateral sclerosis. J. Am. Chem. Soc. 138, 5351&#x2013;5362 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27054659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg M. J., Bystr&#xf6;m R., Bokn&#xe4;s N., Andersen P. M., Oliveberg M., Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl. Acad. Sci. U.S.A. 102, 9754&#x2013;9759 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1174986</ArticleId><ArticleId IdType="pubmed">15987780</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson A.-K. E., et al. , Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species. PLoS One 5, e10064 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2852398</ArticleId><ArticleId IdType="pubmed">20404910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg M. J., Normark J., Holmgren A., Oliveberg M., Folding of human superoxide dismutase: Disulfide reduction prevents dimerization and produces marginally stable monomers. Proc. Natl. Acad. Sci. U.S.A. 101, 15893&#x2013;15898 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC528748</ArticleId><ArticleId IdType="pubmed">15522970</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Chiu C. Y., Mullenbach G. T., Viezzoli M. S., Synthesis and characterization of a monomeric mutant Cu/Zn superoxide dismutase with partially reconstituted enzymic activity. Eur. J. Biochem. 234, 855&#x2013;860 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8575445</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins D., English A. M., SOD1 oxidation and formation of soluble aggregates in yeast: Relevance to sporadic ALS development. Redox Biol. 2, 632&#x2013;639 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052529</ArticleId><ArticleId IdType="pubmed">24936435</ArticleId></ArticleIdList></Reference><Reference><Citation>Outeiro T. F., et al. , Formation of toxic oligomeric &#x3b1;-synuclein species in living cells. PLoS One 3, e1867 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2270899</ArticleId><ArticleId IdType="pubmed">18382657</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenreiro S., et al. , Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity. Hum. Mol. Genet. 25, 275&#x2013;290 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26586132</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson J. R., Register E., Curotto J., Kurtz M., Kelly R., An improved protocol for the preparation of yeast cells for transformation by electroporation. Yeast 14, 565&#x2013;571 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9605506</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe1;zaro D. F., et al. , Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet. 10, e1004741 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230739</ArticleId><ArticleId IdType="pubmed">25393002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenreiro S., et al. , Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson&#x2019;s disease. PLoS Genet. 10, e1004302 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4014446</ArticleId><ArticleId IdType="pubmed">24810576</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro P. S., et al. , LRRK2 promotes tau accumulation, aggregation and release. Mol. Neurobiol. 53, 3124&#x2013;3135 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26014385</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M. D. C., De Mesquita J. F., Eleutherio E. C. A., In vivo characterization of I91T Sod2 polymorphism of Saccharomyces cerevisiae. J. Cell. Biochem. 118, 1078&#x2013;1086 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27584980</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro F. A., Mariani D., Panek A. D., Eleutherio E. C., Pereira M. D., Cytotoxicity mechanism of two naphthoquinones (menadione and plumbagin) in Saccharomyces cerevisiae. PLoS One 3, e3999 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2600608</ArticleId><ArticleId IdType="pubmed">19098979</ArticleId></ArticleIdList></Reference><Reference><Citation>Trevisol E. T. V., Panek A. D., Mannarino S. C., Eleutherio E. C. A., The effect of trehalose on the fermentation performance of aged cells of Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 90, 697&#x2013;704 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21243352</ArticleId></ArticleIdList></Reference><Reference><Citation>Steels E. L., Learmonth R. P., Watson K., Stress tolerance and membrane lipid unsaturation in Saccharomyces cerevisiae grown aerobically or anaerobically. Microbiology 140, 569&#x2013;576 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8012580</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamis P. D. B., et al. , Lap4, a vacuolar aminopeptidase I, is involved in cadmium-glutathione metabolism. Biometals 22, 243&#x2013;249 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18716881</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickland L. H., The determination of small quantities of bacteria by means of the biuret reaction. J. Gen. Microbiol. 5, 698&#x2013;703 (1951).</Citation><ArticleIdList><ArticleId IdType="pubmed">14908008</ArticleId></ArticleIdList></Reference><Reference><Citation>Rona G., et al. , CTT1 overexpression increases life span of calorie-restricted Saccharomyces cerevisiae deficient in Sod1. Biogerontology 16, 343&#x2013;351 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25573485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>